Kieger Healthcare Chart of the Month - Kieger
icon-menu-open Created with Sketch.
icon-menu-close Created with Sketch.
Kieger
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
News
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
Kieger Healthcare Chart of the Month

Kieger Healthcare Chart of the Month

With the continuously increasing number of ESG-data it is becoming more and more difficult to use ESG for investment ideas, this is why it is extremely important to focus on what is material for a company.

Hi, I am Maria Specogna from Kieger.

Our team invests in the Healthcare sector. As the chart shows, around 60% of the ESG controversies in the healthcare industry are related to social issues.

Governance issues due to questionable corporate behaviour are also material and account for 36%. The number of environmental controversies, however, is quite low as manufacturing in the sector is highly regulated and management of environmental issues tend to be good. Intuitively it makes sense that social controversies are so important, as healthcare products have a significant impact on society.  

Unfortunately, there are many examples in the past of big product recalls due to serious side effects.  Recalls will continue to happen in the future, as medicines tend to have potential side effects, this cannot be completely avoided. 

What does it mean for healthcare investors? Should we avoid healthcare because of ESG? Not at all! But we need to have a strong process in order to select the right investments. We focus on companies with responsible strategies to monitor the safety and quality of their products and we also analyse how management proceeds in case of a product recall. With this process, we aim to identify investment opportunities that provide solutions to the key healthcare challenges ahead. Ensuring global well-being and health is critical to the sustainable development goals in the future.

If you would like to know more about our process for ESG integration, do not hesitate to contact us.

Related News

Healthcare
7. June 2023

ASCO – American Society of Clinical Oncology Conference

We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.

Healthcare
1. June 2023

Kieger Healthcare Monthly Commentary

What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.

Healthcare
25. May 2023

Kieger Healthcare Chart of the Month

With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.

Contact

icon-menu-close Created with Sketch.

Get in contact with us by using the form below or via telephone. We look forward to hearing from you.

Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something went wrong. Try again later.

Thank you!

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.

Kieger jobs

icon-menu-close Created with Sketch.

There are no job vacancies at the moment.